Vaccine makers should plan to adjust COVID-19 jabs - WHO

Reuters2021-12-03

GENEVA, Dec 3 (Reuters) - Makers of COVID-19 vaccines should gear up for the "likelihood" of needing to adjust their products to protect against the Omicron variant, the World Health Organization's (WHO) spokesperson said on Friday.

Christian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was studying the transmissibility and severity of the variant first detected in southern Africa last month.

"It is very recommendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine," he said.

"That's good not just to wait until the final alarm bell rings," he said.

Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the emergence of the Omicron variant, its CEO Ugur Sahin told the Reuters Next conference on Friday.

South African scientists studying the Omicron outbreak believe symptoms are less severe for those reinfected with COVID-19 by the new variant or infected after vaccination, a top scientist said on Thursday.

Maria van Kerkhove, the WHO's technical lead on COVID-19, said on Wednesday that the body expected to have more information on the transmissibility of the new Omicron variant "within days".

"It will still take some time and let's not rush into conclusions here," Lindmeier said on Friday.

"Preliminary data, and we have said that now since awhile, show that there is higher transmissibility. But that's all that we basically have so far," he said.

Delta remains the dominant variant globally, accounting for more than 90% of infections, Lindmeier said.

"So Omicron may be on the rise, and we may come to point where it takes over to be the dominant variant, but at this point the very dominant variant remains Delta," he said.

"The restrictions that were put into place in many countries just two weeks ago, economic closures again, lockdowns in some areas, closure of Christmas markets in parts of Europe, this was done before Omicron because of a rise in Delta cases.

Let's not lose sight of this," he added.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • MN27
    2021-12-06
    MN27
     Like pls
  • robot1234
    2021-12-05
    robot1234
    Current vaccines are hardly effective. Gen 2 vaccines will be needed. Another round of tens of billions dollars profit for the manufacturers
  • PearlynCSY
    2021-12-04
    PearlynCSY
    The new Covid variant omicron will likely “overwhelm the whole world” in the coming months, according to a Singapore-based infectious disease doctor. While vaccines against the strain can be developed quickly, they need to be tested over three to six months to prove that they can provide immunity against the variant, Dr. Leong Hoe Nam of Mount Elizabeth Novena Hospital said Wednesday.
  • FALCON
    2021-12-03
    FALCON
    Like
  • sgrs
    2021-12-03
    sgrs
    Interesting
  • JKJKJK
    2021-12-03
    JKJKJK
    Pls help to like
发表看法
7